
p53 Inhibits Lung Cancer Proliferation and Invasion by Regulating miR-34a and Epithelial-Mesenchymal Transition Transformation
Lung cancer is a major cause of cancer-related death. Exploring the mechanism of lung cancer is important for the treatment. In our study, p53 level was knockdown in lung cancer A549 cells and real-time quantitative PCR was conducted for measuring miR-34a expression and epithelialmesenchymal
transition (EMT)-related protein expression was detected by immunoblotting. The cell colony formation was measured by colony formation assay and cell migration was measured by a scratch test. After knocking down p53, miR-34a expression was decreased, which was significantly different from
control group. At the same time, epithelial cell marker E-cadherin expression was increased and mesenchymal phenotype marker N-cadherin level was decreased, along with increased cell proliferation, migration and colony formation. p53 inhibits lung cancer proliferation and invasion by regulating
miR-34a and EMT transformation. This study provides an important theoretical basis and clinical basis for targeted treatment of lung cancer to reduce metastasis and recurrence, and improve the treatment efficacy. It can also provide useful ideas for the study of cell migration mechanisms of
other malignant tumors.
Keywords: Epithelial-Mesenchymal Transition; Lung Cancer; p53
Document Type: Research Article
Affiliations: 1: Respiratory Medicine, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang, 161000, China 2: Internal Medicine-Neurology, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang, 161000, China
Publication date: October 1, 2020
- Journal of Biomaterials and Tissue Engineering (JBT) is an international peer-reviewed journal that covers all aspects of biomaterials, tissue engineering and regenerative medicine. The journal focuses on the broad spectrum of research topics including all types of biomaterials, their properties, bioimplants and medical devices, biofilms, bioimaging, BioMEMS/NEMS, biosensors, fibers, tissue scaffolds, tissue engineering and modeling, artificial organs, tissue interfaces, interactions between biomaterials, blood, cells, tissues, and organs, regenerative medicine and clinical performance.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content